Icahn's Icahn Capital Shows New 6.3M Share Stake in Amylin Pharma (AMLN)
Carl Icahn's Icahn Capital latest 13F shows he built a stake in Amylin Pharmaceuticals Inc. (Nasdaq: AMLN).
Icahn showed a new 6,339,653 share stake in AMLN.
Amylin Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of medicines for diabetes, obesity, and other diseases in the United States.
Create E-mail AlertRelated Categories
Insider TradesInsiders' Blog
Stocks Mentioned
+0.12Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
